GABAB receptors are obligatory heterodimers responsible for prolonged neuronal inhibition in the central nervous system. The two receptor subunits are encoded by GABBR1 and GABBR2. Variants in GABBR2 have been associated with a Rett-like phenotype (MIM: 617903), epileptic encephalopathy (MIM: 617904), and milder forms of developmental delay with absence epilepsy. To date, however, no phenotypes associated with pathogenic variants of GABBR1 have been established. Through GeneMatcher, we have ascertained four individuals who each have a monoallelic GABBR1 de novo non-synonymous variant; these individuals exhibit motor and/or language delay, ranging from mild to severe, and in one case, epilepsy. Further phenotypic features include varying degrees of intellectual disability, learning difficulties, autism, ADHD, ODD, sleep disorders, and muscular hypotonia. We functionally characterized the four de novo GABBR1 variants, p.Glu368Asp, p.Ala397Val, p.Ala535Thr, and p.Gly673Asp, in transfected HEK293 cells. GABA fails to efficiently activate the variant receptors, most likely leading to an increase in the excitation/inhibition balance in the central nervous system. Variant p.Gly673Asp in transmembrane domain 3 (TMD3) renders the receptor completely inactive, consistent with failure of the receptor to reach the cell surface. p.Glu368Asp is located near the orthosteric binding site and reduces GABA potency and efficacy at the receptor. GABA exhibits normal potency but decreased efficacy at the p.Ala397Val and p.Ala535Thr variants. Functional characterization of GABBR1-related variants provides a rationale for understanding the severity of disease phenotypes and points to possible therapeutic strategies.

Department of Biomedicine Pharmazentrum University of Basel Klingelbergstrasse 50 70 4056 Basel Switzerland

Department of Pediatrics and Inherited Metabolic Disorders 1st Faculty of Medicine Charles University and General University Hospital Prague Prague Czech Republic

Department of Pediatrics and Inherited Metabolic Disorders 1st Faculty of Medicine Charles University and General University Hospital Prague Prague Czech Republic; Department of Pediatrics 1st Faculty of Medicine Charles University and University Thomayer Hospital Prague Prague Czech Republic

Division of Neuropaediatrics Hospital for Children and Adolescents University Hospital Leipzig Leipzig Germany

Institute of Human Genetics University of Leipzig Medical Center Leipzig Germany

Medigenome Swiss Institute of Genomic Medicine 1207 Geneva Switzerland

Washington University in St Louis St Louis MO USA

Zobrazit více v PubMed

Pin J.P., Bettler B. Organization and functions of mGlu and GABAB receptor complexes. Nature. 2016;540:60–68. doi: 10.1038/nature20566. PubMed DOI

Gassmann M., Bettler B. Regulation of neuronal GABA(B) receptor functions by subunit composition. Nat. Rev. Neurosci. 2012;13:380–394. doi: 10.1038/nrn3249. PubMed DOI

Favuzzi E., Huang S., Saldi G.A., Binan L., Ibrahim L.A., Fernández-Otero M., Cao Y., Zeine A., Sefah A., Zheng K., et al. GABA-receptive microglia selectively sculpt developing inhibitory circuits. Cell. 2021;184:4048–4063.e32. doi: 10.1016/j.cell.2021.06.018. PubMed DOI PMC

Mariotti L., Losi G., Lia A., Melone M., Chiavegato A., Gómez-Gonzalo M., Sessolo M., Bovetti S., Forli A., Zonta M., et al. Interneuron-specific signaling evokes distinctive somatostatin-mediated responses in adult cortical astrocytes. Nat. Commun. 2018;9:82. doi: 10.1038/s41467-017-02642-6. PubMed DOI PMC

Perea G., Gómez R., Mederos S., Covelo A., Ballesteros J.J., Schlosser L., Hernández-Vivanco A., Martín-Fernández M., Quintana R., Rayan A., et al. Activity-dependent switch of GABAergic inhibition into glutamatergic excitation in astrocyte-neuron networks. Elife. 2016;5:e20362. doi: 10.7554/eLife.20362. PubMed DOI PMC

White J.H., Wise A., Main M.J., Green A., Fraser N.J., Disney G.H., Barnes A.A., Emson P., Foord S.M., Marshall F.H. Heterodimerization is required for the formation of a functional GABA(B) receptor. Nature. 1998;396:679–682. doi: 10.1038/25354. PubMed DOI

Kuner R., Köhr G., Grünewald S., Eisenhardt G., Bach A., Kornau H.C. Role of heteromer formation in GABAB receptor function. Science. 1999;283:74–77. doi: 10.1126/science.283.5398.74. PubMed DOI

Kaupmann K., Malitschek B., Schuler V., Heid J., Froestl W., Beck P., Mosbacher J., Bischoff S., Kulik A., Shigemoto R., et al. GABA(B)-receptor subtypes assemble into functional heteromeric complexes. Nature. 1998;396:683–687. doi: 10.1038/25360. PubMed DOI

Jones K.A., Borowsky B., Tamm J.A., Craig D.A., Durkin M.M., Dai M., Yao W.J., Johnson M., Gunwaldsen C., Huang L.Y., et al. GABA(B) receptors function as a heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2. Nature. 1998;396:674–679. doi: 10.1038/25348. PubMed DOI

Shaye H., Stauch B., Gati C., Cherezov V. Molecular mechanisms of metabotropic GABAB receptor function. Sci. Adv. 2021;7:eabg3362. doi: 10.1126/sciadv.abg3362. PubMed DOI PMC

Samanta D., Zarate Y.A. Widening phenotypic spectrum of GABBR2 mutation. Acta Neurol. Belg. 2019;119:493–496. doi: 10.1007/s13760-019-01088-5. PubMed DOI

Yoo Y., Jung J., Lee Y.N., Lee Y., Cho H., Na E., Hong J., Kim E., Lee J.S., Lee J.S., et al. GABBR2 mutations determine phenotype in rett syndrome and epileptic encephalopathy. Ann. Neurol. 2017;82:466–478. doi: 10.1002/ana.25032. PubMed DOI

Vuillaume M.L., Jeanne M., Xue L., Blesson S., Denommé-Pichon A.S., Alirol S., Brulard C., Colin E., Isidor B., Gilbert-Dussardier B., et al. A novel mutation in the transmembrane 6 domain of GABBR2 leads to a Rett-like phenotype. Ann. Neurol. 2018;83:437–439. doi: 10.1002/ana.25155. PubMed DOI

Lopes F., Barbosa M., Ameur A., Soares G., de Sá J., Dias A.I., Oliveira G., Cabral P., Temudo T., Calado E., et al. Identification of novel genetic causes of Rett syndrome-like phenotypes. J. Med. Genet. 2016;53:190–199. doi: 10.1136/jmedgenet-2015-103568. PubMed DOI

Gassmann M., Shaban H., Vigot R., Sansig G., Haller C., Barbieri S., Humeau Y., Schuler V., Müller M., Kinzel B., et al. Redistribution of GABAB(1) protein and atypical GABAB responses in GABAB(2)-deficient mice. J. Neurosci. 2004;24:6086–6097. doi: 10.1523/JNEUROSCI.5635-03.2004. PubMed DOI PMC

Schuler V., Lüscher C., Blanchet C., Klix N., Sansig G., Klebs K., Schmutz M., Heid J., Gentry C., Urban L., et al. Epilepsy, hyperalgesia, impaired memory, and loss of pre- and postsynaptic GABA(B) responses in mice lacking GABA(B(1)) Neuron. 2001;31:47–58. doi: 10.1016/s0896-6273(01)00345-2. PubMed DOI

Xi B., Chen J., Yang L., Wang W., Fu M., Wang C. GABBR1 gene polymorphism(G1465A)isassociated with temporal lobe epilepsy. Epilepsy Res. 2011;96:58–63. doi: 10.1016/j.eplepsyres.2011.04.014. PubMed DOI

Ma S., Abou-Khalil B., Sutcliffe J.S., Haines J.L., Hedera P. The GABBR1 locus and the G1465A variant is not associated with temporal lobe epilepsy preceded by febrile seizures. BMC Med. Genet. 2005;6:13. doi: 10.1186/1471-2350-6-13. PubMed DOI PMC

Sobreira N., Schiettecatte F., Valle D., Hamosh A. GeneMatcher: a matching tool for connecting investigators with an interest in the same gene. Hum. Mutat. 2015;36:928–930. doi: 10.1002/humu.22844. PubMed DOI PMC

Kaupmann K., Schuler V., Mosbacher J., Bischoff S., Bittiger H., Heid J., Froestl W., Leonhard S., Pfaff T., Karschin A., Bettler B. Human gamma-aminobutyric acid type B receptors are differentially expressed and regulate inwardly rectifying K+ channels. Proc. Natl. Acad. Sci. USA. 1998;95:14991–14996. doi: 10.1073/pnas.95.25.14991. PubMed DOI PMC

Karczewski K.J., Francioli L.C., Tiao G., Cummings B.B., Alföldi J., Wang Q., Collins R.L., Laricchia K.M., Ganna A., Birnbaum D.P., et al. The mutational constraint spectrum quantified from variation in 141, 456 humans. Nature. 2020;581:434–443. doi: 10.1038/s41586-020-2308-7. PubMed DOI PMC

Taliun D., Harris D.N., Kessler M.D., Carlson J., Szpiech Z.A., Torres R., Taliun S.A.G., Corvelo A., Gogarten S.M., Kang H.M., et al. Sequencing of 53, 831 diverse genomes from the NHLBI TOPMed Program. Nature. 2021;590:290–299. doi: 10.1038/s41586-021-03205-y. PubMed DOI PMC

Stefan E., Aquin S., Berger N., Landry C.R., Nyfeler B., Bouvier M., Michnick S.W. Quantification of dynamic protein complexes using Renilla luciferase fragment complementation applied to protein kinase A activities in vivo. Proc. Natl. Acad. Sci. USA. 2007;104:16916–16921. doi: 10.1073/pnas.0704257104. PubMed DOI PMC

Geng Y., Bush M., Mosyak L., Wang F., Fan Q.R. Structural mechanism of ligand activation in human GABA(B) receptor. Nature. 2013;504:254–259. doi: 10.1038/nature12725. PubMed DOI PMC

Prosser H.M., Gill C.H., Hirst W.D., Grau E., Robbins M., Calver A., Soffin E.M., Farmer C.E., Lanneau C., Gray J., et al. Epileptogenesis and enhanced prepulse inhibition in GABA(B1)-deficient mice. Mol. Cell. Neurosci. 2001;17:1059–1070. doi: 10.1006/mcne.2001.0995. PubMed DOI

Heaney C.F., Kinney J.W. Role of GABA(B) receptors in learning and memory and neurological disorders. Neurosci. Biobehav. Rev. 2016;63:1–28. doi: 10.1016/j.neubiorev.2016.01.007. PubMed DOI

Lujan R., Ciruela F. GABAB receptors-associated proteins: potential drug targets in neurological disorders? Curr. Drug Targets. 2012;13:129–144. doi: 10.2174/138945012798868425. PubMed DOI

Mahdavinasab S.M., Saghazadeh A., Motamed-Gorji N., Vaseghi S., Mohammadi M.R., Alichani R., Akhondzadeh S. Baclofen as an adjuvant therapy for autism: a randomized, double-blind, placebo-controlled trial. Eur. Child Adolesc. Psychiatry. 2019;28:1619–1628. doi: 10.1007/s00787-019-01333-5. PubMed DOI

Erickson C.A., Veenstra-Vanderweele J.M., Melmed R.D., McCracken J.T., Ginsberg L.D., Sikich L., Scahill L., Cherubini M., Zarevics P., Walton-Bowen K., et al. STX209 (arbaclofen) for autism spectrum disorders: an 8-week open-label study. J. Autism Dev. Disord. 2014;44:958–964. doi: 10.1007/s10803-013-1963-z. PubMed DOI

Veenstra-VanderWeele J., Cook E.H., King B.H., Zarevics P., Cherubini M., Walton-Bowen K., Bear M.F., Wang P.P., Carpenter R.L. Arbaclofen in Children and Adolescents with Autism Spectrum Disorder: A Randomized, Controlled, Phase 2 Trial. Neuropsychopharmacology. 2017;42:1390–1398. doi: 10.1038/npp.2016.237. PubMed DOI PMC

Zeman A., Hoefeijzers S., Milton F., Dewar M., Carr M., Streatfield C. The GABAB receptor agonist, baclofen, contributes to three distinct varieties of amnesia in the human brain - A detailed case report. Cortex. 2016;74:9–19. doi: 10.1016/j.cortex.2015.10.005. PubMed DOI

Kalinichev M., Girard F., Haddouk H., Rouillier M., Riguet E., Royer-Urios I., Mutel V., Lütjens R., Poli S. The drug candidate, ADX71441, is a novel, potent and selective positive allosteric modulator of the GABAB receptor with a potential for treatment of anxiety, pain and spasticity. Neuropharmacology. 2017;114:34–47. doi: 10.1016/j.neuropharm.2016.11.016. PubMed DOI

Urwyler S., Mosbacher J., Lingenhoehl K., Heid J., Hofstetter K., Froestl W., Bettler B., Kaupmann K. Positive allosteric modulation of native and recombinant gamma-aminobutyric acid(B) receptors by 2, 6-Di-tert-butyl-4-(3-hydroxy-2, 2-dimethyl-propyl)-phenol (CGP7930) and its aldehyde analog CGP13501. Mol. Pharmacol. 2001;60:963–971. PubMed